A detailed history of 1832 Asset Management L.P. transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, 1832 Asset Management L.P. holds 255,444 shares of EW stock, worth $17.3 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
255,444
Previous 277,458 7.93%
Holding current value
$17.3 Million
Previous $25.6 Million 34.23%
% of portfolio
0.03%
Previous 0.05%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$59.7 - $93.78 $1.31 Million - $2.06 Million
-22,014 Reduced 7.93%
255,444 $16.9 Million
Q2 2024

Aug 13, 2024

SELL
$84.3 - $94.31 $2.52 Million - $2.81 Million
-29,839 Reduced 9.71%
277,458 $25.6 Million
Q1 2024

May 14, 2024

SELL
$72.54 - $95.56 $28 Million - $36.9 Million
-385,935 Reduced 55.67%
307,297 $29.4 Million
Q4 2023

Feb 13, 2024

SELL
$61.71 - $77.76 $6.61 Million - $8.33 Million
-107,143 Reduced 13.39%
693,232 $52.9 Million
Q3 2023

Nov 13, 2023

BUY
$69.28 - $93.38 $55.4 Million - $74.7 Million
800,375 New
800,375 $55.4 Million
Q2 2023

Aug 11, 2023

SELL
$81.41 - $94.33 $2.78 Million - $3.22 Million
-34,115 Reduced 4.2%
777,280 $73.3 Million
Q1 2023

May 12, 2023

BUY
$74.26 - $84.51 $435,534 - $495,651
5,865 Added 0.73%
811,395 $67.1 Million
Q4 2022

Feb 14, 2023

SELL
$68.3 - $87.44 $2.73 Million - $3.49 Million
-39,925 Reduced 4.72%
805,530 $60.1 Million
Q3 2022

Nov 14, 2022

SELL
$82.37 - $107.29 $1.26 Million - $1.64 Million
-15,295 Reduced 1.78%
845,455 $69.9 Million
Q2 2022

Aug 15, 2022

SELL
$86.5 - $128.27 $1.2 Million - $1.78 Million
-13,846 Reduced 1.58%
860,750 $81.8 Million
Q1 2022

May 16, 2022

BUY
$101.96 - $128.34 $12.1 Million - $15.2 Million
118,765 Added 15.71%
874,596 $102 Million
Q4 2021

Feb 15, 2022

SELL
$106.37 - $130.68 $69.7 Million - $85.6 Million
-655,093 Reduced 46.43%
755,831 $99.5 Million
Q3 2021

Nov 15, 2021

SELL
$102.91 - $122.75 $18.5 Million - $22 Million
-179,516 Reduced 11.29%
1,410,924 $161 Million
Q2 2021

Aug 16, 2021

BUY
$83.84 - $104.76 $80.3 Million - $100 Million
957,333 Added 151.21%
1,590,440 $164 Million
Q1 2021

May 17, 2021

BUY
$78.68 - $90.67 $210,469 - $242,542
2,675 Added 0.42%
633,107 $52.7 Million
Q4 2020

Feb 16, 2021

SELL
$71.69 - $91.23 $4.36 Million - $5.55 Million
-60,870 Reduced 8.81%
630,432 $56.8 Million
Q3 2020

Nov 16, 2020

BUY
$67.19 - $87.44 $46.4 Million - $60.4 Million
691,302 New
691,302 $54.6 Million
Q2 2020

Aug 14, 2020

SELL
$57.54 - $76.95 $4.57 Million - $6.11 Million
-79,384 Closed
0 $0
Q1 2020

May 26, 2020

BUY
$52.41 - $81.0 $3.91 Million - $6.04 Million
74,552 Added 1542.88%
79,384 $15.6 Million
Q1 2020

May 14, 2020

SELL
$52.41 - $81.0 $4.43 Million - $6.84 Million
-84,492 Reduced 94.59%
4,832 $918,000
Q4 2019

Feb 14, 2020

BUY
$71.7 - $82.09 $3.29 Million - $3.77 Million
45,869 Added 105.56%
89,324 $20.9 Million
Q3 2019

Nov 14, 2019

BUY
$61.55 - $75.43 $2.51 Million - $3.07 Million
40,723 Added 1490.59%
43,455 $9.44 Million
Q2 2019

Aug 14, 2019

BUY
$55.74 - $64.41 $150,498 - $173,907
2,700 Added 8437.5%
2,732 $507,000
Q2 2018

Aug 14, 2018

BUY
$42.45 - $51.3 $1,358 - $1,641
32 New
32 $5,000
Q1 2018

May 15, 2018

SELL
$37.19 - $47.45 $743 - $949
-20 Closed
0 $0
Q4 2017

Feb 14, 2018

BUY
$33.79 - $39.39 $675 - $787
20
20 $2,000

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $41.9B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track 1832 Asset Management L.P. Portfolio

Follow 1832 Asset Management L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of 1832 Asset Management L.P., based on Form 13F filings with the SEC.

News

Stay updated on 1832 Asset Management L.P. with notifications on news.